386
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Suppression of glomerular damage and apoptosis and biomarkers of acute kidney injury induced by acetaminophen toxicity using a combination of resveratrol and quercetin

, , , , , , ORCID Icon & ORCID Icon show all
Pages 1-7 | Received 09 Aug 2019, Accepted 14 Jan 2020, Published online: 03 Feb 2020

References

  • Al Hymayed, S., et al., 2019. Resveratrol pretreatment ameliorates p53-Bax axis and augments the survival biomarker B-cell lymphoma 2 modulated by paracetamol overdose in a rat model of acute liver injury. Pharmacology, 25, 1–8.
  • Al Hymayed, S., et al., 2019. Suppression of acetaminophen-induced hepatocyte ultrastructural alterations in rats using a combination of resveratrol and quercetin. Ultrastructural Pathology, 43, 162–169.
  • Al-Ani, B., 2013. Resveratrol inhibits proteinase-activated receptor-2-induced release of soluble vascular endothelial growth factor receptor-1 from human endothelial cells. EXCLI Journal, 12, 598–604.
  • Al-Ani, B., et al., 2016. Changes in urinary metabolomic profile during relapsing renal vasculitis. Scientific Reports, 6 (1). Article number: 38074.
  • Blazka, M.E., et al., 1996. Histopathology of acetaminophen-induced liver changes: role of interleukin 1 alpha and tumor necrosis factor alpha. Toxicologic Pathology, 24 (2), 181–189.
  • Burda, S. and Oleszek, W., 2001. Antioxidant and antiradical activities of flavonoids. Journal of Agricultural and Food Chemistry, 49 (6), 2774–2779.
  • Cudmore, M.J., et al., 2012. Resveratrol inhibits the release of soluble fms-like tyrosine kinase (sFlt-1) from human placenta. American Journal of Obstetrics and Gynecology, 206, 25.
  • Dallak, M., et al., 2019. Metformin suppresses aortic ultrastructural damage and hypertension induced by diabetes: a potential role of advanced glycation end products. Ultrastructural Pathology, 43 (4–5), 190–198.
  • Elbe, H., et al., 2018. Resveratrol reduces light and electron microscopic changes in acetaminophen-induced hepatotoxicity in rats: Role of iNOS expression. Ultrastructural Pathology, 42 (1), 39–48.
  • Faghihzadeh, F., Hekmatdoost, A., and Adibi, P., 2015. Resveratrol and liver: A systematic review. Journal of Research in Medical Sciences, 20 (8), 797–810.
  • Frankel, E.N., Waterhouse, A.L., and Kinsella, J.E., 1993. Inhibition of human LDL oxidation by resveratrol. The Lancet, 341 (8852), 1103–1104.
  • Galal, R.M., et al., 2012. Potential protective effect of honey against paracetamol-induced hepatotoxicity. Archives of Iranian Medicine, 15 (11), 674–680.
  • Hawton, K., et al., 2004. UK legislation on analgesic packs: before and after study of long term effect on poisonings. BMJ, 329 (7474), 1076.
  • Henderson, C.J., et al., 2000. Increased resistance to acetaminophen hepatotoxicity in mice lacking glutathione S-transferase Pi. Proceedings of the National Academy of Sciences, 97 (23), 12741–12745.
  • Hermenean, A., et al., 2013. Protective effects of naringenin on carbon tetrachloride-induced acute nephrotoxicity in mouse kidney. Chemico-Biological Interactions, 205 (2), 138–147.
  • Hinson, J.A., et al., 2004. Acetaminophen-induced hepatotoxicity: role of metabolic activation, reactive oxygen/nitrogen species, and mitochondrial permeability transition. Drug Metabolism Reviews, 36 (3–4), 805–822.
  • Hinson, J.A., Roberts, D.W., and James, L.P., 2010. Mechanisms of acetaminophen-induced liver necrosis. Handbook of Experimental Pharmacology, 196, 369–405.
  • Hung, L.M., et al., 2000. Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovascular Research, 47 (3), 549–555.
  • James, L.P., Mayeux, P.R., and Hinson, J.A., 2003. Acetaminophen-induced hepatotoxicity. Drug Metabolism and Disposition, 31 (12), 1499–1506.
  • Karaali, H.F., Fahmi, R.R., and Borjac, J.M., 2018. Effect of Ocimum basilicum leaves extract on acetaminophen-induced nephrotoxicity in BALB/c mice. Journal of Complementary and Integrative Medicine, 16.
  • Kitada, M. and Koya, D., 2013. Renal protective effects of resveratrol. Oxidative Medicine and Cellular Longevity, 2013, 568093.
  • Larson, A.M., et al., 2005. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology, 42 (6), 1364–1372.
  • Little, M.A., et al., 2012. Anti-proteinase 3 anti-neutrophil cytoplasm autoantibodies recapitulate systemic vasculitis in mice with a humanized immune system. PLoS One, 7 (1), e28626.
  • Mcgill, M.R., et al., 2012. The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation. Journal of Clinical Investigation, 122 (4), 1574–1583.
  • Mour, G., et al., 2005. Acute renal dysfunction in acetaminophen poisoning. Renal Failure, 27 (4), 381–383.
  • Murota, K. and Terao, J., 2003. Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Archives of Biochemistry and Biophysics, 417 (1), 12–17.
  • Nasr, A.Y., 2013. Morphological, biochemical, histological, and ultrastructural protective effects of misoprostol on cisplatin induced-hepatotoxicity in adult male rats. Saudi Medical Journal, 34 (12), 1237–1247.
  • Ostapowicz, G., et al., 2002. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Annals of Internal Medicine, 137 (12), 947–954.
  • Prescott, L.F., et al., 1977. Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. The Lancet, 2, 432–434.
  • Rogerio, A.P., et al., 2007. Anti-inflammatory activity of quercetin and isoquercitrin in experimental murine allergic asthma. Inflammation Research, 56 (10), 402–408.
  • Sener, G., et al., 2006. Protective effects of resveratrol against acetaminophen-induced toxicity in mice. Hepatology Research, 35 (1), 62–68.
  • Wojnarova, L., et al., 2015. Sirtuin 1 modulation in rat model of acetaminophen-induced hepatotoxicity. Physiological Research, 64, S477–S87.
  • Yang, H., et al., 2018. Quercetin treatment improves renal function and protects the kidney in a rat model of adenine-induced chronic kidney disease. Medical Science Monitor, 24, 4760–4766.
  • Zhang, J., et al., 2017. Quercetin and baicalein suppress monocrotaline-induced hepatic sinusoidal obstruction syndrome in rats. European Journal of Pharmacology, 795, 160–168.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.